Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
基本信息
- 批准号:10197160
- 负责人:
- 金额:$ 43.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
The field of pharmacology has a direct impact on the health and care of the U.S. population. Located at The
Johns Hopkins University School of Medicine, the Department of Pharmacology and Molecular Sciences (DPMS)
is well-positioned to provide superb career training in the broad field of Pharmacology. The training mission of
the Pharmacology and Molecular Sciences (PMS) Training Program is centered on providing trainees with state-
of-the-art research knowledge and professional skills focused on drug design, mechanism of action and the
process of development and translation. Our broad objective is to prepare a diverse pool of budding scientist-
scholars for a variety of pharmacology-related careers. The Program curriculum and activities are specifically
designed to provide training that covers each component of the drug discovery and development pipeline and to
nurture a positive training experience. We accomplish this objective through numerous activities designed to
develop trainee core competencies and preparation for careers in pharmacology. In addition to mentored
laboratory research, our program has four training components: 1) specialized and broad coursework in the
areas of basic and clinical pharmacology, physiology, bioorganic chemistry, drug discovery and biomedical
sciences, 2) collaborative ties to the Lieber Institute for Brain Development (LIBD), which exposes students to a
translational biotech research environment, and the Division of Clinical Pharmacology, which offers training in
the areas of clinical and translational pharmacology, 3) multi-faceted pharmacology-focused career building and
networking activities through our extensive alumni and pharmaceutical career connections and institutional
resources, and 4) multi-faceted pharmacology-related training in the responsible conduct of research and
methods to enhance reproducibility that are ongoing throughout training. With the above plan we arm our trainees
with the requisite knowledge base, technical and professional skills needed to be successful in the broad field of
pharmacology. Our success in achieving these objectives will be measured through validated assessment
instruments covering the courses, training activities, Doctorate Board Oral/Written Exams, and through external
reviews. Importantly, we strive to provide a pathway for our trainees to attain skills that allow them to achieve
work-life balance and to positively impact society in their chosen career paths. The Program intends to recruit
and retain nine new trainees each year who will be supported by this training grant for their first year of training.
In their subsequent years of mentored research, they will be supported by our well-funded and diverse training
faculty. The Program is structured to support appropriate time-to-degree for all trainees (~5 years). We provide
a unique pharmacology-focused career and professional development curriculum and environment that arms
trainees with the skills to adapt to an ever-changing biomedical research landscape and directly facilitates entry
into a broad spectrum of pharmacology-related career paths.
项目概要
药理学领域对美国人口的健康和护理有直接影响。位于
约翰霍普金斯大学医学院药理学和分子科学系 (DPMS)
处于有利地位,可以在广泛的药理学领域提供一流的职业培训。训练任务
药理学和分子科学 (PMS) 培训计划的重点是为学员提供国家-
专注于药物设计、作用机制和药物设计的最先进的研究知识和专业技能
开发和翻译的过程。我们的总体目标是培养多元化的崭露头角的科学家——
各种药理学相关职业的学者。该计划的课程和活动具体是
旨在提供涵盖药物发现和开发流程各个组成部分的培训,并
培养积极的培训体验。我们通过众多旨在实现这一目标的活动
培养学员的核心能力并为药理学职业做好准备。除了辅导之外
实验室研究,我们的计划有四个培训组成部分:1)专业和广泛的课程作业
基础和临床药理学、生理学、生物有机化学、药物发现和生物医学领域
科学,2) 与利伯大脑发育研究所 (LIBD) 的合作关系,使学生能够接触到
转化生物技术研究环境和临床药理学部,提供以下方面的培训:
临床和转化药理学领域,3)以药理学为重点的多方面职业建设和
通过我们广泛的校友和制药职业关系以及机构的网络活动
资源,以及 4) 负责任地进行研究和实施的多方面药理学相关培训
在整个培训过程中不断提高可重复性的方法。通过上述计划,我们武装我们的学员
具备在广泛领域取得成功所需的必要知识基础、技术和专业技能
药理。我们在实现这些目标方面的成功将通过经过验证的评估来衡量
涵盖课程、培训活动、博士委员会口试/笔试以及外部考试的工具
评论。重要的是,我们努力为我们的学员提供获得技能的途径,使他们能够实现
工作与生活的平衡,并在他们选择的职业道路上积极影响社会。该计划拟招募
每年保留九名新学员,他们将在第一年的培训中获得培训补助金的支持。
在随后几年的指导研究中,他们将得到我们资金充足且多样化的培训的支持
学院。该计划旨在支持所有学员获得适当的学位时间(约 5 年)。我们提供
独特的以药理学为中心的职业和专业发展课程和环境,
学员具备适应不断变化的生物医学研究环境并直接促进进入的技能
进入广泛的药理学相关职业道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caren L. Freel Meyers其他文献
Synthesis and biological activity of novel 5-fluoro-2'-deoxyuridine phosphoramidate prodrugs.
- DOI:
10.1021/jm000301j - 发表时间:
2000-10-10 - 期刊:
- 影响因子:7.3
- 作者:
Caren L. Freel Meyers;Liping Hong;Liping Hong;Carolyn Joswig;Carolyn Joswig;R. Borch;R. Borch - 通讯作者:
R. Borch
Caren L. Freel Meyers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caren L. Freel Meyers', 18)}}的其他基金
Targeting DXP synthase in bacterial metabolism
靶向细菌代谢中的 DXP 合酶
- 批准号:
10372207 - 财政年份:2021
- 资助金额:
$ 43.89万 - 项目类别:
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10317255 - 财政年份:2021
- 资助金额:
$ 43.89万 - 项目类别:
Targeting DXP synthase in bacterial metabolism
靶向细菌代谢中的 DXP 合酶
- 批准号:
10576858 - 财政年份:2021
- 资助金额:
$ 43.89万 - 项目类别:
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10641824 - 财政年份:2021
- 资助金额:
$ 43.89万 - 项目类别:
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10470350 - 财政年份:2021
- 资助金额:
$ 43.89万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10385766 - 财政年份:2020
- 资助金额:
$ 43.89万 - 项目类别:
Pharmacology and Molecular Sciences Training Program: Enhancing Inclusivity Through Universal Design for Learning in Graduate Courses
药理学和分子科学培训计划:通过研究生课程学习的通用设计增强包容性
- 批准号:
10592034 - 财政年份:2020
- 资助金额:
$ 43.89万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10617205 - 财政年份:2020
- 资助金额:
$ 43.89万 - 项目类别:
相似国自然基金
低强度超声激励功能化纳米砷烯抗三阴性乳腺癌的药理学机制及可视化研究
- 批准号:82304544
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
针对甲状腺乳头状癌侵袭性功能基因的网络药理学建模及药物筛选研究
- 批准号:
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:
PACS2通过TMX1负调控“内质网-线粒体关联结构”作为IDH突变型胶质瘤治疗的药理机制研究
- 批准号:82304524
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于G6Pase表达调控因子RORα的抗2型糖尿病药物结构药理学探索
- 批准号:82304588
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
苯并呋喃-6-酮类化合物TT01f通过调控Jagged1/Notch信号通路改善特发性肺纤维化的药理学机制研究
- 批准号:82304596
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Center for Cancer Systems Therapeutics (CaST)
癌症系统治疗中心 (CaST)
- 批准号:
10729383 - 财政年份:2023
- 资助金额:
$ 43.89万 - 项目类别:
CSHL Single Cell Analysis Course (2023-2027)
CSHL单细胞分析课程(2023-2027)
- 批准号:
10627446 - 财政年份:2023
- 资助金额:
$ 43.89万 - 项目类别:
2023 Cellular and Molecular Mechanisms of Toxicity Gordon Research Conference and Seminar
2023细胞和分子毒性机制戈登研究会议暨研讨会
- 批准号:
10672627 - 财政年份:2023
- 资助金额:
$ 43.89万 - 项目类别:
Significance of Epac signaling in renal Na+ handling and hypertension
Epac 信号在肾钠处理和高血压中的意义
- 批准号:
10864073 - 财政年份:2023
- 资助金额:
$ 43.89万 - 项目类别:
Influence of T-Stellate Cell Input on Sound Processing in the Inferior Colliculus
T 星状细胞输入对下丘声音处理的影响
- 批准号:
10824666 - 财政年份:2023
- 资助金额:
$ 43.89万 - 项目类别: